glp 1 api Frontiers Liraglutide API for Obesity and
Description
Rumsey D
FDA Approves Mounjaro (Tirzepatide) for Diabetes Treatment. DiaTribe, Last modified Sept
The recent appearance of highly effective AOMs, semaglutide and tirzepatide, heralds a new era in the treatment of obesity
These effects support gradual weight loss and are associated with improvements in cardiometabolic risk factors (18)
While this study did show lowered blood glucose levels, GLP-1RA treatment improved retinal thickness, morphology, and vasculature [82]
